In October 2025, Guo Lab at Shenzhen Bay Laboratory (SZBL) successfully hosted a distinguished seminar on Research Progress in Early Diagnosis and Treatment of Alzheimer’s Disease (AD). The event brought together leading experts to discuss the latest advancements in AD research, especially in early diagnostic technologies and therapeutic approaches.

        The seminar featured notable guest speakers from Institute for Stroke and Dementia Research, LMU University Hospital, Munich, Germany, including: Dr. Nicolai Franzmeier, Dr. Sebastian Romer, and Dr. Lukas Frontzkowski. These experts shared their cutting-edge research in Alzheimer's Disease, focusing on brain neuroimaging, tau pathology, and the mechanisms behind AD progression. Dr. Tengfei Guo also invited several distinguished scholars from Chinese universities and hospitals, including Dr. Zixuan Lin, Tenure-Track Professor at Zhejiang University, who presented on Vascular Contributions to AD and Related Dementias via Physiological MRI at the seminar; Dr. Feng Han, Assistant Professor at Zhejiang University, who discussed The Role of Global Brain Activity in Alzheimer’s Disease; and Dr. Fang Xie, Professor at Fudan University’s Huashan Hospital, who shared Preliminary Results for PET Imaging of Chinese Preclinical Alzheimer’s Disease. The seminar also highlighted advancements in neuroimaging technologies such as MRI and PET, which are crucial for improving early diagnosis and understanding of Alzheimer’s Disease and related dementias.

        The event provided an opportunity for cross-disciplinary collaboration and exchange of innovative ideas, aimed at addressing the public health challenges associated with Alzheimer’s Disease. With contributions from leading experts in the field, the seminar emphasized the critical role of advanced imaging and early diagnosis in shaping future therapeutic strategies for AD. Guo Lab and the whole SZBL remain committed to pushing the boundaries of scientific innovation in neurodegenerative disease research, with continued efforts to promote early diagnosis and treatment.